Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002;80(6):49-52.

[Nimesil effectiveness in rheumatoid arthritis]

[Article in Russian]
R M Balabanova, B S Belov, N V Chichasova, Iu A Oliunin, V V Badokin, A O Pchelintseva, T P Fedina, D A Gukasian, N E Lopatina, N I Korshunov, E Ia Baranova, E P Ilivanova, S E Trifonova, G K Matsievskaia
  • PMID: 12138804

[Nimesil effectiveness in rheumatoid arthritis]

[Article in Russian]
R M Balabanova et al. Klin Med (Mosk). 2002.

Abstract

Clinical efficiency and safety of nimesil were studied in the multicenter open clinical trial of 52 patients with verified rheumatoid arthritis. Nimesil was given for 12 weeks in a daily dose 200-400 mg in addition to basic therapy. Clinical and laboratory parameters were assessed after 4 and 8 weeks of the treatment and after its end. The treatment produced a significant positive response of the articular syndrome. Marked improvement was registered in 11 (23.4%) patients, improvement--in 33 (79.2%) patients. Side effects were reversible and occurred in 8 (15.3%) patients. In 5 patients the drug was withdrawn. The conclusion is made on high efficiency and good tolerance of nimesil in rheumatoid arthritis patients.

PubMed Disclaimer

Publication types